Search

everythinglearnresearchcommunity

for

Search:↓

Clinical pharmacists are crucial in improving patient safety by reporting medication errors in hospitals.

Dermatologists can help diagnose endocrine disorders like PCOS and metabolic syndrome by looking at skin symptoms.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

High Nesfatin-1 and low Vitamin D may increase blood pressure and heart rate in women with PCOS.

A postmenopausal woman's virilization was caused by a rare ovarian tumor that was hard to detect but was successfully treated with surgery.

Women with PCOS may be more likely to have gum disease than healthy women.

Menopausal acne is treated with medications and lifestyle changes, but careful choice is needed due to side effects.

Rutin may help treat symptoms of polycystic ovary syndrome (PCOS) in rats.

Higher hs-CRP levels in Indian adolescent women with PCOS are more related to BMI than PCOS itself.

Diagnosing PCOS in teenagers is hard because its symptoms often look like normal puberty, and there's a need for better diagnosis methods and agreement on criteria.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

Women with PCOS are much more likely to have sleep problems and should be checked for them.

Indian women with PCOS may need different ultrasound criteria for diagnosis than current standards.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

PPARγ is essential for maintaining healthy skin, controlling inflammation, and ensuring proper skin barrier function.

People with polycystic ovary syndrome have a higher chance of having chronic thyroiditis.

Women with PCOS are more likely to have sleep apnea, mainly if they are obese.

More than half of the women with PCOS in Southern India had Metabolic Syndrome, with large waist circumference being the most common feature.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Ultrasound measurement of the ovarian stroma to total area ratio is not a reliable single predictor of high male hormone levels in Thai women with PCOS, but works better when combined with clinical signs.

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

The PCOS-specific questionnaire needs more work to fully measure quality of life in clinical trials.

SVF and PRP improve hair loss, but SVF causes more side effects.

High androgen levels in Chinese women with PCOS are linked to a higher risk of diabetes and obesity.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Dialysis patients benefit from water-soluble vitamins but need careful management to avoid risks.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Microneedling with PRP and minoxidil (5%) improves hair growth more than minoxidil (5%) alone.